Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SHEL LAB Introduces the Bactrox Chamber

Published: Tuesday, May 15, 2012
Last Updated: Monday, May 14, 2012
Bookmark and Share
Ideal for low oxygen conditions in microaerophilic bacteriology, tissue & cell culture applications.

Sheldon Manufacturing, Inc. has introduced the SHEL LAB Bactrox Chamber, the latest addition to its industry leading Bactron line of anaerobic chambers. The Bactrox offers precise oxygen and carbon dioxide control from 1-20%.

The SHEL LAB Bactrox Chamber (http://www.shellab.com/store/lab-products/Bactrox) preserves optimal application conditions not only during incubation but also in the chamber work station.

Removal of cultures from the incubator does not require exposure of cells to undesirable oxygen or carbon dioxide levels.

The unit’s advanced atmospheric controller allows for the use of a highly accurate and long-lasting zirconium dioxide oxygen sensor, with independent oxygen and carbon dioxide control and logging.

The Bactrox also has a standalone 300 plate incubator so users can comfortably work without gloves in ambient room conditions.

“It is exciting to bring this type of technology to our Bactron line. Most importantly, it broadens the scope of research that can be performed by our customers,” states Dan Sheldon, President of Sheldon Manufacturing, Inc.

To minimize set-up time, the Bactrox includes an extra- large vacuum-less sample pass box that takes only sixty seconds to purge. The new design provides a vacuum-less sleeve entry into the chamber.

Other features of this unit include temperature control and logging, superior condensation control, and ultra bright LED examination lights inside the chamber.

The Bactrox is ideal for stem cell research, mammalian cancer research and clinical and research microbiology, and joins the SHEL LAB line of Bactron Anaerobic Chambers (http://www.shellab.com/store/categories/1-bactron-chambers/) including the BacBASIC, and Bactron I, II, III and IV.

The Bactrox is available through SHEL LAB distribution partners.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Stem Cells Rescue Patients from Mitochondrial Disease
A study led by OHSU researchers has revealed a critical first step in developing a new gene and stem cell regenerative technique for treating patients with mitochondrial disease.
Eco-Friendly Nanobullet to Battle Bacteria
Researchers have developed a method to combat bacteria by engineering nanoscale particles that add the antimicrobial potency of silver to a core of lignin, a ubiquitous substance found in all plant cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!